INS and Hypoglycemia: Rates of combined level 2 or 3 hypoglycemia were similar and low for icodec and other basal insulins groups: 0.19 events per PYE with icodec and 0.14 events per PYE with other basal insulins at week 52, respectively (estimated rate ratio = 1.17; 95% CI: 0.73 to 1.86).